Article · 26 Feb 2026
Mini reviewPublished 30 Jan 2023
Disulfide-rich recombinant proteins from Plasmodium falciparum can be efficiently produced using Lactococcus lactis as a platform.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recently, it was discovered that Lactococcus lactis is an effective Gram-positive cell factory for the production of recombinant protein. This term “host” has been used by us and others to develop a few malaria vaccine candidates. Numerous clinical trials have confirmed this production system’s safety. In this study, we investigated L. lactis cell factories for the production of 31 representative Plasmodium falciparum antigens with varying sizes and predicted structural complexities. Among these antigens were eleven that had multiple predicted structural disulfide bonds, which are proteins that are thought to be difficult to produce.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Bioprocessing.
Article · 29 Nov 2025
Adaptive Bioprocess Control: Enabling Intelligent and Robust Biomanufacturing
Article · 29 Nov 2025
Advanced Foam Control Strategies in Bioprocessing
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Bioprocessing
- SubjectPharmaceutical Sciences
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “David Gouveiac”